IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study

NCT07034664 · clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

The Third Xiangya Hospital of Central South University